CDC says it is on the ground in Texas to aid in measles outbreak response
The Centers for Disease Control and Prevention (CDC) is on the ground in Texas to aid the state in tamping down a measles outbreak, the agency said Tuesday.
The agency in a statement on the social platform X said it has sent some of its Epidemic Intelligence Service (EIS) 'disease detectives' to the West Texas region, the same day the state reported an additional 13 cases, bringing the total to 159.
Twenty-two of the patients have been hospitalized and one child has died, the first measles death in the U.S. in a decade and the first death in a child in the U.S. since 2003.
The CDC's participation means Texas officials requested federal assistance, since the agency can't send a team without an official state ask.
The partnership, known as an Epi-Aid, is a rapid-response effort in which the Epidemic Intelligence Service Officers — the 'disease detectives' — will provide local officials support for one to three weeks, the CDC said. The local authority leads the investigation while collaborating with CDC experts.
'The measles outbreak in Texas is a call to action for all of us to reaffirm our commitment to public health. By working together — parents, healthcare providers, community leaders, and government officials, we can prevent future outbreaks and protect the health of our nation,' Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said in a statement.
Kennedy last week said the CDC was providing 'technical assistance and vaccines' to help with the outbreak, including lab support and sending doses of the measles-mumps-rubella (MMR) vaccines.
The outbreak has largely spread within a community of Mennonites in Gaines County, who historically have had lower vaccination rates.
A longtime vaccine skeptic, Kennedy initially downplayed the outbreak during a Cabinet meeting with President Trump last week, saying it was 'not unusual' and falsely claiming that many people hospitalized were there 'mainly for quarantine.'
He still has not openly encouraged vaccination, though in an op-ed posted on the Fox News website Sunday he urged parents to talk with their doctors 'to understand their options to get the MMR vaccine' while emphasizing that the decision to get vaccinated was a 'personal one.'
In a prerecorded Fox News interview Tuesday, Kennedy said HHS was shipping doses of vitamin A to Gaines County, the epicenter of the outbreak, and was helping to arrange ambulance rides.
Kennedy did not explicitly endorse vaccinations in the interview.
He claimed doctors in the area have reported 'very very good results' from treating patients with a steroid called budesonide, an antibiotic called clarithromycin and cod liver oil, which he said had high concentrations of Vitamin A and Vitamin D.
Vitamin A has been used for years in children in developing countries with severe measles, but doctors have said the evidence of its effectiveness is mixed. It isn't used widely in the U.S., likely because children aren't Vitamin A deficient.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
A New COVID Variant Is Here, And It's More Transmissible — Here Are The Signs And Symptoms
A new COVID variant known as NB.1.8.1 has made landfall in the United States. The variant, which was first detected in China this past January, currently accounts for 10% of the SARS-CoV-2 sequences tested from around the world, recent surveillance data found. That's a significant jump from 2.5% four weeks ago. A Centers for Disease Control and Prevention (CDC) spokesperson told HuffPost that the agency is in regular contact with international partners about the activity of NB.1.8.1. To date, only 20 NB.1.8.1 sequences have been identified in the U.S. — that's below the threshold needed for a variant to appear on the agency's COVID dashboard. (As soon as its prevalence increases, NB.1.8.1 will pop up on the tracker, the spokesperson added.) It's nerve-wracking to hear that a new variant is making the rounds, but infectious disease specialists say there are no glaring differences between the symptoms of NB.1.8.1 and those caused by other versions of SARS-CoV-2. 'Currently it appears that NB.1.8.1 would have similar symptoms to other COVID variants that have recently been circulating,' Dr. Zachary Hoy, a pediatric infectious disease specialist with Pediatrix Medical Group in Nashville, Tennessee, told HuffPost. Here's what to know about the newest COVID variant that's gaining traction around the world. Compared to the currently dominant variant in the U.S. (LP.8.1), NB.1.8.1 has a handful of new mutations on the spike protein that may enhance its ability to bind to our cells, according to the World Health Organization (WHO). The agency suspects these mutations will increase the virus's transmissibility and, potentially, diminish the effectiveness of neutralizing antibodies that prevent pathogens from latching to our cells. In other words, the variant may be skilled at dodging some of our immune defenses, research suggests. According to Dr. Amesh Adalja, an infectious diseases expert and senior scholar at the Johns Hopkins University Center for Health Security, NB.1.8.1's symptoms are pretty much the same as those seen with other SARS-CoV-2 variants. Two of COVID's hallmark symptoms are a mild but persistent dry cough and nasal congestion, Hoy said. Many people who come down with COVID are also hit with fatigue and tiredness. 'An infected person can still make it through the day, but they are resting more and feel more tired throughout the day,' Hoy said. Other common symptoms include a fever, chills, a sore throat and muscle aches. 'Some have described recent variants as less intense symptoms as compared to wintertime influenza viruses, but both can have severe symptoms,' Hoy said. There's no evidence suggesting the variant causes more severe disease or an uptick in hospitalizations or deaths, the WHO states. The only noticeable aspect, as of now, is that it's rising in prevalence, Adalja said. It's too early to know exactly how effective the shots are — as the research on NB.1.8.1 is limited since it's so new — but scientists expect the shots to hold up well. NB.1.8.1 broke off from the Omicron JN.1 lineage, which the 2024-2025 vaccines target. 'The ability of the vaccines to prevent severe illness is intact though protection versus infection is limited and transient,' Adalja said. Anyone who is at risk of severe disease should stay up-to-date with the shots. 'Those in older populations or with underlying immune disorders or on immune-decreasing medications would benefit more from vaccination or those with increased exposure such as healthcare workers,' Hoy added. So if you have a condition that puts you at risk, it's worth getting vaccinated if it's been more than six months since your last vaccine or bout of COVID, Adalja advises. He also added that those who are low-risk likely do not need to go out and get another shot. Most people will be able to recover at home by resting and staying hydrated. While you're sick, acetaminophen and ibuprofen can help alleviate muscle aches and fevers, Hoy said. And, in most cases, symptoms should clear up within a week. For those who are at risk for severe disease, including older adults and people who are immune-compromised, it's worth contacting a physician as they can prescribe antivirals — Paxlovid and Molnupiravir — that can significantly lower the risk of severe complications and death. As was the case with previous variants, these antivirals work best when started within five days of symptom onset. As for when you should go to an urgent care or emergency room? When you have chest pain, have a hard time waking up or staying awake, or feel confused and disoriented, the CDC advises. Hoy says the most concerning symptom he warns patients about is difficulty breathing. 'If you have COVID or COVID-like illness and have worsening trouble breathing or chest pain, you should be evaluated at your doctor's office, urgent care or the ER,' he said. RFK Jr. Says COVID Shot Will No Longer Be Advised For Healthy Kids, Pregnant Women Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried New Trump Vaccine Policy Limits Access To COVID Shots
The Hill
2 hours ago
- The Hill
Beyond MAHA: Defeating obesity requires a new strategy
Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that number is, it is perhaps even more surprising that nearly 20 percent of children in the U.S. are obese. Obesity leads to significant health challenges, including diabetes, stroke, cardiovascular disease and liver disease. It is clear that as a nation we must face this crisis on multiple fronts. Diet and exercise certainly help, and it's critical to ensure that people of all socioeconomic backgrounds have access to healthy foods (free of preservatives, unnecessary dyes, high fructose corn syrups etc.) and are educated in making healthy lifestyle choices. The MAHA or 'Make America Healthy Again' movement has highlighted this as one of its key objectives, and if it is successful, we should see an impact on obesity — especially in children, where diet and exercise have a huge impact on weight-related health outcomes. Obesity in adults, however, is often more challenging. Many adults with obesity struggle to lose weight, despite considerable efforts to modify their lifestyle through diet and exercise. This is because our metabolism changes as we age, and many adults who are overweight develop metabolic dysfunction or 'metabolic syndrome,' which then further perpetuates weight gain and exacerbates the situation. It has become clear in recent years that many people struggling with obesity require medical intervention – not just lifestyle intervention – and that prescriptions can substantially improve weight loss. The explosion in use of GLP-1 agonists, such as Wegovy and Zepbound, over the last two years has underscored the need for medical intervention in obese and overweight patients. Currently, about 6 percent of the U.S. population, or 15 million people, are on GLP-1 weight loss treatments, and the numbers are only expected to increase. However, while most patients lose 10 percent to 25 percent of their body weight while on a GLP-1, they do not maintain GLP-1 treatment in the long-term, with approximately 80 percent of patients discontinuing treatment within 1 year. Gastrointestinal side effects, injectable administration, and high cost have prevented long-term use of GLP-1's for weight maintenance. And unfortunately, most patients gain back all the weight after stopping the medication. Healthcare professionals and the pharmaceutical industry now recognize that obesity — like most other medical conditions — requires an 'arsenal' of treatments, rather than a one-size-fits-all approach. Post-GLP-1 weight maintenance is now widely recognized as an emerging unmet need. And patients who are not candidates for or cannot tolerate GLP-1s require alternatives. Diet and lifestyle modifications are important alongside prescription medications in fighting obesity. If we are going to be successful in overcoming this major health crisis, we need to ensure that both the pharmaceutical industry and groups like MAHA work hand in hand. Both treatment and prevention are critical in order to regain control of our nation's health. Dr. Shoshana Shendelman, Ph.D. is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs and therapeutics for rare and underserved diseases. Currently she is Vice Chair of the Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.
Yahoo
3 hours ago
- Yahoo
Israeli military kills 4 near aid distribution site in Gaza, medics say
TEL AVIV/GAZA (Reuters) -Four people were killed and others injured by Israeli forces on Sunday as Palestinians making their way to an aid distribution site in the southern Gaza Strip came under fire, according to Palestinian paramedics. The Israeli military said in a statement that troops had opened fire in southern Gaza but said that it had directed warning shots at a group that was moving towards soldiers and deemed a threat to them. It was the latest bout of shooting near aid distribution points in Gaza's south since a controversial Israeli- and U.S.-backed group, the Gaza Humanitarian Foundation, began handing out aid late last month. Palestinian paramedics said they had evacuated the bodies of four people who were killed early on Sunday near an aid distribution venue in the southern Gaza city of Rafah. Media affiliated with Gaza's dominant Hamas militant group reported that the Israeli military had opened fire near a distribution site in Rafah operated by the GHF. The Israeli military statement said the people towards whom warning shots were fired before dawn on Sunday had been verbally warned to leave the area, which was considered an active military zone at the time. The military has said people should only move to and from the GHF distribution centres between 6 a.m. and 6 p.m., with non-daylight hours considered a closed military period. The military acknowledged reports of injuries but did not specify how many people it believed had been hurt or shot. Sanaa Doghmah said her husband, Khaled, 36, was fatally shot in the head while trying to reach a distribution site in Rafah to collect food for their five children. "He was going to get food for his children and himself, to make them live, feed them because they don't have a pinch of flour at home," Khaled's aunt, Salwah, said at his funeral. The GHF, which is handing out aid under an Israeli initiative that is bypassing traditional relief agencies who say their deliveries into Israeli-blockaded Gaza have been restricted, did not immediately respond to requests for comment. GHF: AID HANDED OUT The U.S.-based organisation earlier said in a Facebook post that aid was distributed in central and southern Gaza on Sunday. It had handed out no aid on Saturday, accusing Hamas of making threats that "made it impossible" to operate in the enclave, which the Islamist group denied. The GHF uses private American military contractors to operate its sites and has been accused of a lack of neutrality and independence by U.N. and other international humanitarian agencies. It has denied such accusations. Israel relented to international pressure to allow limited U.N.-led operations to resume on May 19 after an 11-week blockade in the enclave of 2.3 million people, where experts have warned a famine looms. The U.N. has described the aid allowed into Gaza as "drop in the ocean." While the GHF has said there have been no incidents at its so-called secure distribution sites, Palestinians seeking aid have described scenes of disorder and access routes to the sites have been beset by chaos and deadly violence. Dozens of Palestinians were killed near GHF sites on June 1-3, Gaza health authorities said. Israel's military has said it was investigating the incidents but that warning shots were fired in each incident, and that on Tuesday it had also fired at Palestinians advancing towards troops. The GHF did not give out aid on Wednesday as it pressed Israel to boost civilian safety beyond its sites, then on Friday it paused some aid distribution "due to excessive crowding." The Israeli military said on Saturday that 350 trucks of humanitarian aid belonging to the U.N. and other international relief groups were transferred this week via the Kerem Shalom crossing into Gaza. The war erupted after Hamas-led militants took 251 hostages and killed 1,200 people, most of them civilians, in the Oct. 7, 2023 attack, Israel's single deadliest day. Israel's military campaign has since killed more than 54,000 Palestinians, most of them civilians, according to health authorities in Gaza, and flattened much of the coastal enclave.
